Jefferies Financial Group reissued a 'buy' rating on Monte Rosa Therapeutics, whose stock trades on the Nasdaq exchange.

The entities involved

• Monte Rosa Therapeutics →

  biotechnology company

  Nothing else this week.

• Jefferies Financial Group →

  American financial services company

  • Jefferies Financial Group cut Alfen's stock rating to 'hold' on October 31, 2026.07:50
  • Financial firms including Truist, RBC, TD Cowen, and Jefferies issued various rating updates on October 30, 2026.07:04
• Nasdaq →

  American fully electronic stock exchange

  • RadNet filed required reports with the SEC and traded on the Nasdaq stock exchange.07:03
  • Maya is pursuing a domestic listing and has filed financial statements with the SEC, with foreign partners potentially eyeing a Nasdaq listing.03:46
• Nasdaq →

  American fully electronic stock exchange

  • Nasdaq decline triggered a selloff across the chip sector.03:25
  • A tech selloff drove the Nasdaq index to its worst day on October 30, 2026.03:25

Related events

• Jefferies Financial Group restated a buy rating on Wise shares.Oct 19
• Jefferies Financial Group reaffirmed a Buy rating on London Stock Exchange Group.Oct 23
• Jefferies Financial Group and Raymond James Financial reaffirmed buy ratings on Compass Pathways stock, which MarketBeat is tracking.Jul 20
• Jefferies Financial Group reiterated a buy rating on Chrysalis Investments shares on October 1, 2026.Oct 17
• Jefferies Financial Group upgraded Flowco shares to buy rating on August 11, 2026.Aug 12